Our Work


Site

  • Khayelitsha and NHLS Tygerberg / Stellenbosch University, South Africa

Investigator

  • Jean Maritz (Alere q)

Studies Planned

  • Laboratory validation (NHLS TBH)
    Field evaluation in Khayelitsha primary care in partnership with MSF

  • KEMRI/CDC HIV-research branch Kisumu, Kenya

  • Valarie Opollo (GeneXpert)

  • Awaiting CDC approval for multi-country evaluation of POC EID
    Collaborative study with MSF on GeneXpert (IESS study)

  • Centre for Infectious Disease Research in Zambia (CIDRZ)  

  • Izukanji Sikazwe

  • No current EID POC evaluations
    GeneXpert laboratory evaluation (NMRL)

  • National Microbiology Reference Laboratory (NMRL),(with CHAI and MSF), Harare, Zimbabwe

  • Ellen Munemo (GeneXpert; Alere q)

  • GeneXpert and Alere q field evaluation (6 field sites and Gutu)

  • Dar es Salaam and Iringa, Tanzania

  • Victor Muchunguzi (GeneXpert; Alere q)

  • Field evaluations

  • Infectious Diseases Institute / Johns Hopkins, Uganda

  • Yuka Manabe

  • No current EID POC evaluations

  • Planned CDC multi-country evaluation in 4 countries – Kenya, Cote d’Ivoire, Cameroon, Ethiopia

  • Karidia Diallo (planned: Alere q; GeneXpert)

  • Laboratory evaluation: WHO / CDC / NHLS collaboration
    Field evaluation (5 countries)

  • CDC Retro CI laboratory, Cote D’Ivoire

  • Ramatou Toure Adechoubou (Alere q; GeneXpert)

  • Evaluations planned

  • University of Cape Town, South Africa

  • Landon Myer

  • ELaboratory evaluation – NHLS laboratory Groote Schuur Hospital
    Field evaluation – Gugulethu & Mowbray MOUs

  • Baragwanath Hospital EID POC study, WITS, South Africa

  • Gayle Sherman (Alere q; GeneXpert)